UK markets open in 5 hours 1 minute
NIKKEI 225
38,294.70 +92.33 (+0.24%) HANG SENG
18,415.70 +101.84 (+0.56%) CRUDE OIL
79.29 +0.30 (+0.38%) GOLD FUTURES
2,318.50 -3.80 (-0.16%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,241.16 -786.50 (-1.57%)
Caribou Biosciences, Inc. (CRBU)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 3.7300 |
| Open | 3.6400 |
| Bid | 3.4900 x 400 |
| Ask | 3.5200 x 800 |
| Day's range | 3.4400 - 3.7000 |
| 52-week range | 3.4400 - 8.5900 |
| Volume | |
| Avg. volume | 1,645,118 |
| Market cap | 316.112M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates
Caribou Biosciences (CRBU) delivered earnings and revenue surprises of -17.95% and 19.03%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
With 65% institutional ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) is a favorite amongst the big guns
Key Insights Institutions' substantial holdings in Caribou Biosciences implies that they have significant influence...
- Zacks
All You Need to Know About Caribou Biosciences, Inc. (CRBU) Rating Upgrade to Buy
Caribou Biosciences, Inc. (CRBU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
© 2024 Yahoo. All rights reserved.